Alex Kim, Chief Operating Officer and Standard BioTools Co-Founder, to Serve as interim Chief Financial Officer Following Departure of Jeffrey Black on August 31, 2024 Industry Veteran Sean Mackay Named Chief Business Officer SOUTH SAN FRANCISCO, Calif. — Standard BioTools Inc. (“Standard BioTools” or the “Company”) (Nasdaq: LAB) today announced that Jeffrey Black, Chief Financial Officer, will resign […]
WESTBURY, NY – BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, today announced the appointment of Dr. Judith Dunn and Dr. Auro Nair to its Board of Directors. “Judy’s wealth of experience across the drug discovery to clinical spectrum with both large pharma and biotech companies will help us further deepen […]
Maravai announces the appointment of CEO Trey Martin to its Board of Directors, highlighting his leadership, commitment to innovation, and industry experience SAN DIEGO — Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced that its CEO William “Trey” Martin, III has been appointed […]
Dr Thomas Buer succeeds Dr Manfred Jagiella as managing director Dr Thomas Buer will become the new managing director of Endress+Hauser Liquid Analysis on 1 October 2024. He succeeds Dr Manfred Jagiella, who is retiring at the end of September after 17 years at the helm of the competence center for liquid analysis. Manfred Jagiella […]
Carlsbad, Calif. – Arima Genomics, Inc., a company leveraging 3D genomics to reveal actionable insights that will empower researchers and clinicians to improve human health, today announced the appointment of Raees Ebrahim to the position of Vice President of Sales. In this role, Raees will be responsible for executing strategic sales initiatives, nurturing relationships with […]
SAN FRANCISCO – Illumina Ventures, a leading genomics and precision health venture firm, today announced that Timothy Stenzel, MD, PhD, and Jerry Steiner have joined the team as Advisors. Together, they bring more than 60 years of executive leadership experience in molecular diagnostics and agribusinesses, respectively. Dr. Stenzel is the former director of the US Food and […]
Key appointment brings extensive software commercial experience to drive global growth CAMBRIDGE, UK – Optibrium, a leading developer of software and AI solutions for drug discovery and molecular design, today announced the appointment of James Halle as Chief Commercial Officer (CCO). James brings extensive software experience in the pharma industry and will guide the commercial success […]
BrightSpec, the market leader in Molecular Rotational Resonance (MRR) spectroscopy solutions, announced today the appointment of two new executives to drive the commercialization of their growing portfolio of precision instruments and analytical tools. BrightSpec develops and commercializes instruments that harness the power of MRR spectroscopy, an innovative approach to rapidly and definitively characterize the unique […]
Former Agena Bioscience EVP and GM to lead Mission Bio’s marketing, sales, and customer support efforts SOUTH SAN FRANCISCO, Calif. – Mission Bio, a leader in single-cell multiomics solutions for precision medicine, today announced the appointment of Roman Haehn as Chief Commercial Officer. Drawing on more than 25 years of experience in diagnostics and life sciences […]
Chicago – Sysmex America, Inc., a leading diagnostic solutions company offering hematology, hemostasis, urinalysis, flow cytometry and information systems, today announced that longtime healthcare executive Dan Zortman has been named the company’s new CEO. Andy Hay, who has served as CEO since 2021, will continue to serve as Chairman and President of Sysmex America with a […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
